Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans

Çolpan, Aylin; Johnston, Brian; B. Porter, Stephen; Clabots, Connie; Anway, Ruth; Thao, Lao; A. Kuskowski, Michael; Tchesnokova, Veronika; V. Sokurenko, Evgeni; R. Johnson, James; behalf of the VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators, on; L. Allen, Bradley; Baracco, Gio; Bedimo, Roger; Bessesen, Mary; A. Bonomo, Robert; M. Brecher, Stephen; T. Brown, Sheldon; M Castellino, Laila; S. Desai, Arundhati; Fernau, Fletcher; Fisher, Mark; M. Fleckenstein, James; S. Fleming, Carol; J. Fries, Narla; L. Kan, Virginia; A. Kauffman, Carol; Klutts, Stacey; Ohl, Michael; A. Russo, Thomas; Swiatlo, Andrea; Swiatlo, Edwin

doi:10.1093/cid/cit503

Public

Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans

Published in Clinical Infectious Diseases • Aug 6, 2013

Authors:

Aylin Çolpan

Brian Johnston

Stephen B. Porter

Abstract

BACKGROUND: Escherichia coli sequence type 131 (ST131), typically fluoroquinolone-resistant (FQ-R) and/or extended-spectrum β-lactamase (ESBL)-producing, has emerged globally. We assessed its prevalence and characteristics among US veterans. METHODS: In 2011, 595 de-identified E. coli clinical isola...

Subject

Escherichia coli

Multiple drug resistance

Pathogen

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!